Lynn D. Cinelli is a globally recognized healthcare executive and supply chain strategist whose 20+ year career exemplifies leadership at the intersection of innovation, operational excellence, and inclusive, purpose-driven impact. With a technical foundation in biological engineering, Lynn has held senior roles across multinational pharmaceutical companies including Bristol Myers Squibb and Merck & Co., where she has transformed complex, global supply chains and influenced public health outcomes on a global scale. Her technical breadth as well as exposure to policy, lean operations and strategy development and execution positions her as an thought partner cross functional operator.

Most recently serving as Vice President of Global Supply Chain for Biologics at Bristol Myers Squibb, Lynn leads a team of over 175 professionals responsible for the end-to-end supply of sterile and biologic products generating more than $20 billion in annual revenue. Her leadership ensures seamless alignment across oncology, immunology, and cardiovascular portfolios, encompassing more than 600 SKUs across internal and external networks. Under her stewardship, the organization has accelerated product launches such as QVANTIG and REBLOZYL, exited product allocations, and implemented groundbreaking digital supply planning tools like SAP S/4HANA and Kinaxis Maestro. Lynn is also a key executive voice on the Bio OpU and Supply Chain Leadership teams, driving long-term strategy, digital transformation, and public policy engagement.

Prior to BMS, Lynn held multiple executive roles at Merck, where she shaped the strategic direction of its $3.5B global vaccines portfolio as Global Vaccines Value Chain Leader. Her impact spanned lifecycle design, public-private partnerships, and vaccine access strategies, including the market rollout of ERVEBO and ROTATEQ and Merck’s response to the COVID-19 pandemic. Lynn was also the enterprise-wide Strategy & Operations Lead to the EVP of Policy & Strategic Communications, where she spearheaded Merck’s Policy Academy and led external engagement across pricing, IP, ESG, and health equity.

Lynn’s global lens is rooted in her diverse experiences across Asia Pacific, Europe, and North America. She served as Merck’s Regional Policy Director for Asia Pacific, where she influenced policy outcomes on IP, trade, and access in complex markets such as India, Vietnam, and Malaysia. She led innovative affordability pilots in Indonesia and shaped regional oncology access initiatives. Her early career featured leadership in vaccine supply, capital projects, and end-to-end planning across the lifecycle—including as Global Product Leader for pneumococcal vaccines launch and Immunology Supply Chain Manager for the $3B REMICADE/SIMPONI portfolio as it entered Biosimilar competition. .

Beyond her corporate roles, Lynn is a passionate champion of inclusion, mentorship, and public health. She is a Global DEI Leader and EMpower Top 100 Future Leader, recognized for advancing equity within and beyond the workplace. She has served on influential boards including the Cornell Engineering Alumni Association and the US-Taiwan Business Council and volunteers as a guest lecturer at Cornell University’s Applied Operations Strategy course.  She also shares her thought leadership through her appointment on the editorial board of Outsourced Pharma – a Life Science Connect publication.  She is an Executive Ambassador for Merck for Mothers and a vocal advocate for maternal health, health equity, and supply chain resilience.

Lynn holds degrees from Cornell University in Biological Engineering (BS, MEng), executive education from Georgetown University and Simmons School of Management, and certifications including Lean Six Sigma Black Belt and APICS CSCP. She has published peer-reviewed research and remains a visible thought leader in supply chain innovation, policy, and diversity strategy.

Lynn Cinelli brings a rare fusion of technical depth, strategic acumen, and global empathy to everything she touches—making her not only a transformative leader in life sciences, but also a trusted advisor, inclusive mentor, and lifelong builder of sustainable systems that serve both business and society.

Character
Lynn Cinelli exemplifies integrity, resilience, and a deep commitment to purpose-driven leadership, consistently fostering inclusive teams and championing equity across global organizations. Her unwavering dedication to public health, mentorship, and responsible innovation reflects her core values and enduring impact on both industry and community.

Knowledge
With a robust foundation in biological engineering and decades of cross-functional leadership, Lynn brings deep expertise in global supply chain strategy, policy, product lifecycle management, and vaccine commercialization. Her academic and professional credentials, combined with board involvement and international experience, position her as a thought leader in both technical and strategic domains.

Strategic
Lynn’s strategic vision has enabled transformative results, from optimizing global supply networks to shaping access and policy in complex markets. She leads with foresight, aligning long-term enterprise goals with innovation, risk mitigation, and sustainability to create resilient, high-impact systems across health ecosystems.

Communication
A trusted executive partner and policy advocate, Lynn communicates with clarity, influence, and empathy, driving alignment across stakeholders from boardrooms to governments. She is a skilled facilitator of cross-functional dialogue and a compelling voice for organizational purpose, shaping narratives that drive understanding and action.